Olympus Corporation CEO Stefan Kaufmann looks to the future of the company in their Integrated Report 2023
Posted:
"Ensuring patient safety is our top priority and becoming a global MedTech company recognized for its innovative products and solutions, as well as its people." . Read more in his whole interview here.
Pharmacy researchers in Hong Kong have developed an AI-driven tool that predicts cardiovascular risks beyond genetics, monitoring near-real-time biological changes before diseases become apparent.
Read more here.
Automated radiomics-based artificial intelligence tools are being evaluated as decision-support systems that may assist radiologists in lesion detection and risk assessment while fitting into established prostate cancer diagnostic pathways.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us